Ruomei Qi

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Inflammatory Response

Top Venues

Oxidative medicine and cellular longevity

BMC complementary medicine and therapies

BMC complementary and alternative medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Huilian Chen, Shenghao Zhang, Hui Wang, Li Bao, Wei Wu, Ruomei Qi
Fruitflow inhibits platelet function by suppressing Akt/GSK3β, Syk/PLCγ2 and p38 MAPK phosphorylation in collagen-stimulated platelets. BMC complementary medicine and therapies 22 (1) (2022)
Yun Xue, Huilian Chen, Shenghao Zhang, Li Bao, Beidong Chen, Huan Gong, Yanyang Zhao, Ruomei Qi
Resveratrol Confers Vascular Protection by Suppressing TLR4/Syk/NLRP3 Signaling in Oxidized Low-Density Lipoprotein-Activated Platelets. Oxidative medicine and cellular longevity 2021 (2021)
Ming Zhang, Yun Xue, Huilian Chen, Lingbing Meng, Beidong Chen, Huan Gong, Yanyang Zhao, Ruomei Qi
Resveratrol Inhibits MMP3 and MMP9 Expression and Secretion by Suppressing TLR4/NF-κB/STAT3 Activation in Ox-LDL-Treated HUVECs. Oxidative medicine and cellular longevity 2019 (2019)
Ming Zhang, Jie Sun, Beidong Chen, Yanyang Zhao, Huan Gong, Yun You, Ruomei Qi
Ginkgolide B inhibits platelet and monocyte adhesion in TNFα-treated HUVECs under laminar shear stress. BMC complementary and alternative medicine 18 (1) (2018)
Kun Chen, Wenjia Sun, Yun Jiang, Beidong Chen, Yanyang Zhao, Jie Sun, Huan Gong, Ruomei Qi
Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs. Oxidative medicine and cellular longevity 2017 (2017)